添加微信 添加微信
添加微信
首页: 全球医药政策

瑞士-NDA Regulatory Science (NDA Group)

时间:2021-10-21 15:57:55 来源:康安医药咨询 作者:康安医药咨询

NDA is a world leading drug development consultancy with a dedicated team of over 150 consultants supported by an expert network and a specialist Advisory Board. Our goal is to streamline drug development in order to accelerate patient access to important medical therapies. We are an independent, private, family-owned business solely focused on giving pharmaceutical companies objective, impartial advice on how to accelerate patient access to important medical therapies. With NDA our clients work with a single partner linking science, medicine, regulation and reimbursement considerations to optimise development timelines. Our experts supported the development of the regulatory and reimbursement systems in place today.NDA has no clinical research arm and therefore no interest in driving unnecessary clinical research – we only focus on what you need and what the regulators and payers require.

Phone: +41, (0)78, 951, 9929 E-mail: zurich@ndareg.com
Web: https://www.ndareg.com
Add:Rigistrasse 5 8703 Erlenbach Switzerland

想要下载更多资料,请您添加微信了解详情!

微信号:csco2022

公众号:康安医药咨询

当前栏目

频道栏目

最新文章

热门文章